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Abstract
Introduction: The study objectives were to evaluate septic shock-
induced alterations in skeletal muscle hemoglobin oxygenation
saturation (StO2) using near-infrared spectroscopy (NIRS) and
forearm skin blood flow velocity using laser Doppler (LD) to
determine the relationship of macroperfusion and microperfusion
parameters, and to test the relationship of the worst NIRS
parameters during the first 24 hours of shock with 28-day
prognosis.
Methods: A prospective, observational study was performed in a
21-bed university hospital surgical intensive care unit. Forty-three
septic shock patients with at least another organ failure underwent
a 3-minute, upper arm (brachial artery) vascular occlusion test
(VOT). Microperfusion parameters (thenar eminence StO2  and
forearm LD skin blood flow) were collected on days 1, 2 and 3,
before (baseline StO2 and LD values) and during the 3-minute
VOT with calculation of occlusion and reperfusion slopes for StO2
and LD. Daily Sequential Organ Failure Assessment (SOFA) score,
macrohemodynamic parameters (systolic arterial blood pressure,
cardiac output (pulmonary artery catheter or transesophageal
Doppler), mixed venous oxygen saturation (pulmonary artery or
superior vena cava catheter)) and metabolic parameters (pH, base
excess, lactate) were determined.
Results: Baseline StO2 (82% (75 to 88) vs. 89% (85 to 92),
P = 0.04) and reperfusion slope (2.79%/second (1.75 to 4.32) vs.
9.35%/second (8.32 to 11.57), P <0.0001) were lower in septic
shock patients than in healthy volunteers. StO2 reperfusion slope
correlated with occlusion slope (P <0.0001), cardiac output
(P = 0.01) and LD reperfusion slope (P = 0.08), and negatively
with lactate level (P = 0.04). The worst StO2 reperfusion slope
during the first day of shock was lower in nonsurvivors than in
survivors (P = 0.003) and improved significantly the predictive
value of Simplified Acute Physiology Score II and SOFA scores.
Conclusions: The alteration of StO2 reperfusion slope in septic
shock patients compared with healthy volunteers was related with
macrohemodynamic, microhemodynamic and metabolic parameters.
The addition of the worst value of the day 1 StO2 reperfusion slope
improved the outcome prediction of Simplified Acute Physiology
Score II and SOFA scores.
Introduction
Septic shock is described as a distributive shock, requiring
fluid and vasopressor administration [1]. In the recent past,
evidence for microcirculatory failure as a motor of organ
failure during septic shock has grown. It has been shown that
distribution of flow within a tissue is impaired by oxygen
shunting [2,3], cell aggregation, thrombosis [4], vaso-
constriction [5] and/or tissue edema [6]. In the early phase of
septic shock, early goal-directed cardiovascular optimization
seems more efficient than the conventional strategy [7].
Despite this strategy, some patients continue to have
abnormal microperfusion [8], which has been proposed to be
targeted therapeutically with a fluid challenge [8], nitric oxide
donors [9,10] or activated protein C [11,12]. Before
integrating microperfusion parameters into clinical strategies,
a better characterization and understanding of microperfusion
abnormalities is needed.
Among the tools available for microperfusion assessment,
near-infrared spectroscopy (NIRS) seems promising. It has
been shown in different life-threatening conditions that tissue
hemoglobin oxygen saturation (StO2) characterizes tissue
hypoperfusion and effectiveness of therapies in trauma
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[13-17], septic shock [18-22], and other acute systemic
inflammatory conditions [23]. The large overlap of StO2
values between healthy subjects and septic shock patients
[15-18] largely limits the interest of this parameter for
individual care. As a consequence, a method to better evaluate
the tissue micro-oxygenation in septic shock is needed. In this
respect, a vascular occlusion test (VOT) combined with StO2
measurement has been proposed [17-20].
Measuring StO2 with a VOT provides a functional test having
several potential determinants. These determinants and their
relative impact during septic shock remain to be clarified so
they can be interpreted adequately before making decisions.
The StO2 occlusion slope was shown to relate to tissue
oxygen consumption [18,19,24], and the StO2 reperfusion
slope was proposed to evaluate tissue flow reperfusion and
vascular recruitment [18,22] and was found to be abnormal in
septic shock [20-22]. The purpose of the present study was
to quantify the micro-oxygenation parameters in a homo-
geneous septic shock population controlled for severity, to
investigate the relationship of micro-oxygenation and macro-
perfusion parameters, to investigate the relationship of NIRS
parameters and skin laser Doppler (LD) in the same
conditions, and to evaluate the association between micro-
oxygenation parameters and outcome.
Materials and methods
The present single-center study was prospectively
conducted in the 21-bed surgical intensive care unit at the
tertiary Lariboisière University Hospital, between January
2005 and August 2008. The study was approved by the
Ethics Committee of the French Society of Intensive Care
(CE-SRLF 07-185) and informed consent was given by
patients’ next of kin.
Patients
Forty-three patients suffering from septic shock and with at
least one additional organ failure were consecutively enrolled.
Septic shock was diagnosed according to the criteria given
by the Consensus Conference [1]. Measurements were
performed as early as possible within the first 24 hours after
starting vasopressor therapy (norepinephrine >0.05 μg/kg/
minute). All septic shock patients were enrolled except those
in which monitoring StO2 on the thenar eminence was not
possible (one patient).
All patients were mechanically ventilated and invasively
monitored for hemodynamic parameters with arterial and
central venous catheters (Vigilance PreSep CEDV(X3820HS);
Edwards Lifesciences, Irvine, CA, USA) or pulmonary artery
catheters (Swan Ganz CCOmboV CCO/SvO2/CEDV;
Edwards Lifesciences), with continuous measurement of
central venous oxygen saturation (ScvO2) or mixed venous
oxygen saturation (SvO2), respectively. Cardiac output was
also measured, either by the thermodilution technique or by
esophageal Doppler (CardioQ ED probe; Deltex, Brighton,
UK) [25]. Light sedation and analgesia were provided
according to the evaluation of individual needs by the
physician in charge (flunitrazepam 1 to 2 mg/hour and fentanyl
50 to 200 μg/hour, propofol 50 mg/hour, or ketamine 50 to
200 mg/hour). Measurements were performed distant from
modifications in the sedation protocol (at least 6 hours) or in
the cardiovascular support (at least 1 hour). Patients were
treated according to written intensive care unit standard
management for septic shock, very similar to the Surviving
Sepsis Campaign [26]. Additional treatments such as
recombinant human activated protein C, hydrocortisone or
nitric oxide donors were collegially decided. No interventions
were based on measured StO2 parameters.
For each patient, the following data were collected. Routine
laboratory items were measured on the first day of septic
shock to calculate the Simplified Acute Physiology Score II
[27] and the Sequential Organ Failure Assessment (SOFA)
score [28]; repeated for calculation of the SOFA score on
days 2 and 3. Macrohemodynamic parameters measured
were the heart rate, blood pressure, cardiac output, right
atrial pressure, ScvO2 or SvO2 (catheter measurement) and
peripheral oxygen saturation (SpO2) (pulse oximetry Dräger
SC 9000, adult disposable oximetry sensor Novadiem 3311-
V, Nellcor compatible; Drägerwerk AG & Co. KGaA, Lübeck,
Germany). The metabolic parameters of arterial and venous
blood gases, arterial lactate, and hemoglobin concentration
were also collected on days 1, 2 and 3 and were compared
with NIRS-derived parameters. Since SvO2 was measured
either in the superior vena cava (ScvO2) or in the pulmonary
artery (mixed SvO2), we analyzed these data separately and
then pooled the data after applying a correction for the
ScvO2. Five percent was subtracted from the ScvO2 value,
according to previous reports [29]. The day-to-day infusion
rates of vasopressors, inotropes, and analgesic and sedative
drugs during these 72 hours were also collected.
Tissue hemoglobin oxygen saturation measurements
StO2 was measured by a tissue spectrometer (InSpectra
Model 325; Hutchinson Technology, Hutchinson, MN, USA),
which uses reflectance-mode probes to measure scattering
light reflected at some distance from where the light is
transmitted into the tissue. The maximum depth of the tissue
sampled is estimated to equal one-half of the distance
between the probe’s sending and receiving fibers (probe
spacing) [13,30], which was 25 mm in the present study. A
light-scattering calibrator was used to normalize the tissue
spectrometer during system startup and before each
measurement. StO2 measurements were updated every
3.5 seconds [22]. This non-invasive technique measures the
saturation ratio of oxygenated and deoxygenated hemoglobin.
This ratio includes all vessels (arterioles, capillaries and
venules) in the tissue sample volume illuminated by the NIRS
sensor. The decision to measure StO2 at the skeletal muscle
of the thenar eminence was based on several factors: this
area (hand and thenar eminence) is an important target forvascular reflex adaptation [31], having an earlier and more
amplified vascular response than many other tissues [32,33];
there is little signal influence of skin and fat tissue for a
12.5 mm depth of measurement [13,30]; and edema is more
limited on this area [34]. The sensor was placed on the side
free of an arterial catheter to avoid any potential interference.
StO2 monitoring continued for 72 hours after enrollment. In
addition, a VOT was performed four times per day with a
rigorous protocol: after a 5-minute baseline measurement, a
sphygmomanometer cuff placed over the brachial artery was
rapidly inflated to 300 mmHg and maintained for 3 minutes to
achieve stagnant arterial ischemia. The cuff was then abruptly
deflated and measurements continued for 5 minutes.
The following parameters were measured or calculated from
continuous numerical data stored in the device: after
occlusion, the slope for StO2 decay was calculated from six
to nine values and called the occlusion slope; similarly, after
abrupt release of the cuff inflation, the reperfusion slope was
computed on the basis of three or four StO2 ascending
values. The slopes were calculated using statistical linear
adjustment. When the linear correlation coefficient R2 was
>0.90, the slope was considered linear and expressed as a
percentage per second (normal values ± standard deviation:
occlusion slope, –0.46 ± 0.17%/second; reperfusion slope,
9.82 ± 2.11%/second). This strategy for measurements was
repeated on days 1, 2 and 3. At day 1, the worst values for
StO2 and VOT calculated parameters were used in survivors,
nonsurvivors, and healthy subjects (n = 15) for comparison
and for testing the outcome predictable value. Baseline StO2
and VOT parameters for healthy volunteers were collected in
a semirecumbent position after 10 minutes of rest. Data from
days 1, 2, and 3 were pooled for a correlation study between
NIRS parameters, macrohemodynamic data, metabolic data
and LD data. In addition, baseline StO2 values were
compared with other oxygen saturations and the gradients
between StO2 and SvO2 and between SpO2 and StO2 were
computed.
Laser Doppler
The skin blood flow velocity was measured upstream of the
StO2 probe, on the inner side of the homolateral wrist, using
the LD technique. The probe was secured and connected to
a dual-channel flowmeter (BLF21D; Transonic Systems,
Ithaca, NY, USA). Cutaneous blood flow velocity (1.2 mm
deep, in arbitrary tissue perfusion units (TPU)) was con-
tinuously measured and recorded as a numerical signal onto
a computer with an analog/digital transducer (Biopac
Systems MP100; BIOPAC Systems, Inc, Goleta, CA, USA)
and with data processing software (Acqknowledge 3.81;
BIOPAC Systems, Inc).
The same occlusion test used for StO2 was applied for LD
measurements (Figure 1). After baseline data registration,
the stop flow (VOT) and the post-ischemic reperfusion flow
were registered. As shown in Figure 1, the LD flow signal
shows a reperfusion peak flow before coming back to
baseline. In addition to baseline values, the slope of
reperfusion was calculated as described for StO2 using
linear adjustment (normal value ± standard deviation:
baseline, 30.49 ± 21.30 TPU/seconds (local data) [35];
reperfusion slope, 48.62 ± 32.08 TPU/seconds). The
relative reperfusion hyperemia was also calculated from
baseline to peak (absolute TPU value). Data from reperfusion
were expressed as absolute changes, as well as the
percentage of variation from the preocclusion value.
Statistical analysis
Data are summarized as the incidence and percentage for
categorical variables. Quantitative variables are summarized
as the median (25th to 75th percentiles). The reperfusion
slope was dichotomized using the median value, which
allowed fixing the threshold difference. The relationship
between variables at day 1 (scores, macrohemodynamic,
metabolic, NIRS and LD) and death within 28 days were
tested by Wilcoxon test or Fisher exact test. Multivariate
models were performed using multiple logistic regression. In
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Figure 1
Tissue hemoglobin oxygen saturation and laser Doppler measurement.
Example of a real tracing for tissue hemoglobin oxygen saturation
(StO2) and laser Doppler measurements obtained before and during
the occlusion test. TPU, tissue perfusion units.model checking, we examined potential interactions and
colinearity. Goodness of fit was evaluated using the method
proposed by Le Cessie and Van Houwelingen. Models were
compared using the log-likelihood ratio test. We used a linear
mixed-effects model to analyze the pooled data from days 1,
2 and 3, and the relationships between StO2 and SvO2,
between the reperfusion slopes of StO2 and LD, between
StO2 occlusion and reperfusion slopes, and between the
StO2 reperfusion slope and macrohemodynamic or metabolic
data. The predictive value on outcome for the StO2 reper-
fusion slope and SOFA score was calculated using a receiver
operator characteristic curve with data obtained on day 1.
All tests were two-sided, at the 0.05 significance level.




Forty-three patients with septic shock were included in the
study. Clinical characteristics are summarized in Table 1. By
definition, all patients had cardiovascular dysfunction and at
least one other organ dysfunction at the time of recruitment.
According to collegial decision, 11 patients (25.6%) received
recombinant human activated protein C at the recommended
dose rate and duration, 15 patients (34.8%) received low-
dose hydrocortisone (50 mg four times daily) with no
fludrocortisone, and three patients (7%) were treated with
nitric oxide donors (molsidomine, 2 to 4 mg; Sanofi Aventis,
Paris, France) [10]. The age of the 15 healthy volunteers
ranged from 25 to 72 years.
The actual mortality rate was 34.9% (15 patients), consistent
with a group at high risk of death. Of these 15 nonsurviving
patients, two (13.3%) received recombinant human activated
protein C and four (26.6%) received hydrocortisone. There
were no differences in age, sex, primary sites of infection or
Simplified Acute Physiology Score II scores between
survivors and nonsurvivors. The SOFA score on day 1,
however, was higher in nonsurvivors compared with survivors
(median 13 (12 to 16) vs. 9 (8 to 11), P = 0.001).
Among the hemodynamic parameters (Table 2), only cardiac
output was significantly different between survivors and
nonsurvivors (6.8 (5.0 to 8.3) vs. 4.9 (4.1 to 6.9), P = 0.04).
The lactate level was higher in nonsurvivors compared with
survivors (median 6.8 (5.3 to 8.8) vs. 3.1 (2 to 4), P = 0.001),
while the pH and base excess were lower in the former group
of patients than in those who survived (7.2 (7.1 to 7.2) vs. 7.3
(7.2 to 7.4), P <0.001, and –12.3 (–14.25 to –10.4) vs. –7.3
(–10 to –3.8), P = 0.004, respectively) (Table 2). The hemo-
globin concentration showed no difference between both
groups (P = 0.51) and was considered adequate.
The evolution of patients surviving at least the first 3 days is
described in Table 3 for the SOFA score, cardiovascular
support, hemodynamic and metabolic items, StO2 and LD
data. One can note the rapid evolution of the hemodynamic
parameters, norepinephrine dose, metabolic status and StO2
parameters despite a relatively stable day-to-day SOFA score.
Tissue hemoglobin oxygen saturation data
The baseline StO2 was moderately lower in septic shock
patients compared with healthy volunteers (82% (75 to 88)
vs. 89% (85 to 92), P = 0.04). In addition, the reperfusion
slope was lower in septic shock patients compared with
volunteers (median 2.79%/second (1.75 to 4.32) vs.
9.35%/second (8.32 to 11.57), P <0.0001) (Figure 2a,b),
with no difference for occlusion slopes (P = 0.11).
Looking at the survivors versus the nonsurvivors, the two
groups had similar baseline StO2 values (82% (75 to 87) vs.
82% (73 to 92), P = 0.86) and occlusion slopes
(–0.35%/second (–0.54 to –0.24) vs. –0.3%/second (–0.37
to –0.25), P = 0.36) (Table 3). The reperfusion slopes were
significantly lower in nonsurvivors compared with survivors
(median 1.88%/second (1.56 to 2.76) vs. 3.98%/second
(2.25 to 6.04), P = 0.003) on day 1 (Table 3). The difference
for the reperfusion slope between the survivors and
nonsurvivors related to intensive care unit death (odds ratio =
0.46, 95% confidence interval = 0.26 to 0.83).
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Table 1
Demographic and clinical characteristics of septic shock
patients
Characteristic Value
Age (years) 70 (56 to 81)
Sex (men) 25 (58.2)
Sepsis origin
Abdominal 22 (51.2)
Respiratory tract 11 (25.6)
Skin/soft tissue 4 (9.3)
Urinary tract 2 (4.7)
Others 4 (9.3)
Patients with recombinant human activated  11 (25.6)
protein C
Patients with corticoids 15 (34.8)
Patients with nitric oxide donors 3 (7)
Simplified Acute Physiology Score II 57 (46 to 70)
Sequential Organ Failure Assessment score:
Day 1 10 (8 to 13)
Day 2 12 (9 to 14)
Day 3 11 (7 to 14)
Outcome (alive/dead) 28/15 (65/35)
Data are presented as median (25th to 75th percentiles) or n (%).Available online http://ccforum.com/content/13/S5/S6
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Table 2
Hemodynamic and metabolic data and severity scores at day 1
Parameter Total group (n = 43) Survivors (n = 28) Nonsurvivors (n = 15) P-value
Heart rate (beats/minute) 108 (90 to 121) 108 (90 to 113) 110 (89 to 125) NS
Systolic arterial pressure (mmHg) 115 (100 to 121) 115 (103 to 120) 114 (88.5 to 127) NS
Diastolic arterial pressure (mmHg) 55 (47 to 62) 56 (49 to 62) 50 (45 to 62) NS
Cardiac output (l/minute) 5.9 (4.8 to 7.8) 6.8 (5.0 to 8.3) 4.9 (4.1 to 6.9) 0.04
Right atrial pressure (mmHg) 11 (8 to 13) 11 (8 to 13) 12 (9 to 15) NS
pH 7.3 (7.2 to 7.3) 7.3 (7.2 to 7.4) 7.2 (7.1 to 7.2) 0.0003
Base excess (mEq/l) –9.6 (–11.35 to –5.35) –7.3 (–10 to –3.8) –12.3 (–14.35 to –10.4) 0.004
Lactate (mmol/l) 4.1 (2.2 to 5.5) 3.1(2.0 to 4.0) 6.8 (5.3 to 8.8) 0.001
Hemoglobin (g/dl) 9.9 (9.0 to 11.2) 10 (9.2 to 11.1) 9.7 (8.6 to 11.2) NS
SAPS II 57 (46 to 70) 56 (43 to 61) 65 (52 to 79) 0.08
SOFA score 10 (8 to 13) 9 (8 to 11) 13 (12 to 16) 0.001
Data are presented for patients with septic shock (total group), for survivors and for nonsurvivors as median (25th to 75th percentiles). NS, not
significant; SAPS II, Simplified Acute Physiology Score II; SOFA, Sequential Organ Failure Assessment.
Table 3
Evolution of SOFA score, dose of cardiovascular drugs, and systemic and microperfusion parameters in septic shock patients
Parameter n Day 1 n Day 2 n Day 3 
SOFA score 43 10 (8 to 13) 39 12 (9 to 14) 35 11 (7 to 14)
Norepinephrine (μg/kg/minute) 43 0.59 (0.32 to 0.85) 35 0.47 (0.25 to 0.80) 24 0.30 (0 to 0.56)
Epinephrine (μg/kg/minute) 5 0.26 (0.22 to 0.37) 4 0.45 (0.17 to 0.78) 2 0.71 (0.62 to 0.80)
Dobutamine (μg/kg/minute) 4 10 (7 to 11) 4 6 (2 to 10) 2 6.3 (5.7 to 7.0)
Heart rate (beats/minute) 43 108 (90 to 121) 35 101 (80 to 108) 25 80 (74 to 102)
Systolic arterial pressure (mmHg) 43 115 (100 to 121) 35 120 (111 to 130) 25 131 (109 to 147)
Diastolic pressure (mmHg) 43 55 (47 to 62) 35 58 (52 to 64) 25 61 (52 to 68)
Cardiac output (l/minute) 33 5.9 (4.8 to 7.8) 28 6.3 (5.0 to 7.2) 16 5.3 (4.9 to 7.5)
Right atrial pressure (mmHg) 35 11 (8 to 13) 34 10 (7 to 14) 20 10 (6 to 11)
pH 24 7.27 (7.22 to 7.33) 19 7.32 (7.28 to 7.39) 11 7.38 (7.35 to 7.41)
Base excess (mEq/l) 20 –9.6 (–11.4 to –5.4) 18 –4.8 (–8.0 to – 2.4) 11 –3.2 (–6.0 to 0.8)
Lactate (mmol/l) 23 4.14 (2.22 to 5.51) 19 2.30 (1.56 to 5.62) 7 3.00 (1.98 to 3.88)
SvO2 (%) 39 75 (68 to 83) 34 74 (66 to 78) 22 70 (65 to 75)
Hemoglobin (g/dl) 43 9.9 (9.0 to 11.2) 38 9.5 (8.8 to 11.0) 33 9.6 (8.4 to 10.0)
SpO2 (%) 43 99 (98 to 100) 38 99 (97 to 100) 33 99 (98 to 100)
StO2 (%) 43 82 (75 to 88) 36 85 (78 to 92) 25 88 (80 to 92)
StO2 occlusion slope (%/second) 43 –0.31 (–0.47 to –0.24) 34 –0.48 (–0.65 to –0.31) 21 –0.42 (–0.62 to –0.34)
StO2 reperfusion slope (%/second) 43 2.79 (1.75 to 4.32) 34 4.37 (2.98 to 6.72) 21 5.15 (3.67 to 6.85)
LD baseline flow (TPU) 15 2.74 (1.92 to 5.65)  13 5.30 (1.88 to 7.56) 9 6.57 (3.87 to 11.92)
LD reperfusion slope (TPU/second) 15 1.16 (0.49 to 2.64) 13 1.98 (1.58 to 4.36) 9 3.38 (2.42 to 4.31)
Evolution at days 1, 2 and 3 of the Sequential Organ Failure Assessment (SOFA) score, the dose of vasopressor and inotropic drugs, and
systemic (hemodynamic and metabolic) and microperfusion (near-infrared spectroscopy and laser Doppler (LD)) parameters in septic shock
patients. Data are expressed as the median (25th to 75th percentiles). SvO2, central venous oxygen saturation (central venous + added 5% of
saturation or arterial pulmonary blood gases); SpO2, pulse oxymetry; StO2, tissue hemoglobin oxygen saturation; TPU, tissue perfusion units.No difference was observed in the gradients between SpO2
and StO2 or between StO2 and SvO2 in survivors and non-
survivors (Table 3 and Table 4). There was also no correlation
between SpO2 and StO2 (data not shown), nor between
StO2 and SvO2 (P = 0.86) (Figure 3).
Figure 4 shows the significant correlations observed with the
reperfusion slope, which might clarify the determinants of
such a parameter in septic shock. Among the hemodynamic
and metabolic parameters evaluated on days 1, 2, and 3, we
observed a positive correlation between the StO2 reperfusion
slope and cardiac output (P = 0.01) and a negative correla-
tion between the StO2 reperfusion slope and arterial lactate
(P = 0.04). The occlusion and the reperfusion slopes
correlated well: the faster the StO2 decay during the stagnant
ischemia, the faster the reperfusion slope (P <0.0001). No
correlation between the reperfusion slope and blood
pressure, pH or base excess was observed.
The predictive value on outcome of the reperfusion slope was
calculated using a receiver operator characteristic curve. The
receiver operator characteristic curve showed the StO2
reperfusion slope as a good outcome predictor (area under
the curve = 0.77). The best cut-off value was 2.83%/second,
with a sensitivity of 80% and a specificity of 67%. In addition,
using a multivariable model, the StO2  reperfusion slope
Critical Care    Vol 13 Suppl 5 Payen et al.
Page 6 of 11
(page number not for citation purposes)
Figure 2
Baseline tissue hemoglobin oxygen saturation and the reperfusion slope. (a) Box plot for baseline tissue hemoglobin oxygen saturation (StO2) in
healthy volunteers compared with that for septic shock patients on day 1. (b) Box plot for reperfusion slope in healthy subjects compared with that
for septic shock patients on day 1.
Table 4 
Tissue hemoglobin oxygen saturation parameters measured at day 1
Parameter Total group (n = 43) Survivors (n = 28) Nonsurvivors (n = 15) P-value
SpO2 (%) 99 (98 to 100) 99 (97 to 100) 100 (99 to 100) 0.18
StO2 (%) 82 (75 to 88) 82 (75 to 87) 82 (73 to 92) 0.86
SvO2 (%) 75 (68 to 83) 76 (70 to 84) 73 (68 to 77) 0.22
ΔSpO2 – StO2 (%) 17 (9 to 24) 16 (9 to 22) 18 (7.5 to 25) 0.96
ΔStO2 – SvO2 (%) 5 (–7 to 19) 4.5 (–3 to 18.1) 10 (–10.3 to 20.5) 0.61
ΔStO2 – SvO2/StO2 0.06 (–0.1 to 0.2) 0.05 (–0.04 to 0.2) 0.14 (–0.1 to 0.2) 0.69
ΔStO2 – SvO2/SvO2 0.08 (–0.03 to 0.3) 0.05 (–0.03 to 0.3) 0.18 (0 to 0.3) 0.50
Occlusion slope (%/second) –0.31 (–0.47 to –0.24) –0.35 (–0.54 to –0.24) –0.3 (–0.37 to –0.25) 0.36
Reperfusion slope (%/second) 2.79 (1.75 to 4.32) 3.98 (2.25 to 6.04) 1.88 (1.56 to 2.76) 0.003
Tissue hemoglobin oxygen saturation (StO2) parameters measured on day 1 in patients with septic shock (total group), in survivors and in
nonsurvivors. Data are presented as median (25th to 75th percentiles). SpO2, pulse oxymetry; SvO2, central venous oxygen saturation (included
mixed venous oxygen saturation and superior vena cava oxygen saturation + 5%); Δ, gradient between stated parameters.added a significant prognostic value both to the SOFA score
(P = 0.037) (Figure 5) and to the Simplified Acute Physiology
Score II (P = 0.015) (data not shown).
Laser Doppler data
Fifteen (34.8%) out of the 43 septic shock patients were also
evaluated with the skin LD technique. Values obtained for the
total group were: baseline, 2.74 TPU (1.92 to 5.65) (normal
values ± standard deviation: 30.49 ± 21.30); peak value
during the hyperemic phase, 6.67 TPU (5.02 to 9.3); peak
value–baseline difference, 3.62 TPU (1.88 to 4.58); reper-
fusion slope, 1.16 TPU/second (0.49 to 2.64) (normal values ±
standard deviation: 48.62 ± 32.08). There were no significant
differences in these parameters between survivors and
nonsurvivors (data not shown). The LD reperfusion slope
tended to correlate with the StO2 reperfusion slope, but did
not reach statistical significance (P = 0.08) (Figure 4d).
Discussion
This prospective, observational study follows the recently
published study by Creteur and colleagues on severe sepsis
and septic shock using the same device [22]. The primary
new inputs of our study design are the selection of a very
homogeneous population (that is, only septic shock patients
having at least one additional organ failure), two techniques
for microperfusion assessment (StO2 and skin LD), a day 1
evaluation of the predictive value of the reperfusion slope with
a clear difference in median between survivors and non-
survivors, and an investigation of the potential determinants of
the reperfusion slope (systemic hemodynamic and metabolic
parameters such as lactate and the occlusion slope). Our
StO2 parameters in septic shock confirm the observations
made by Creteur and colleagues in septic shock: the muscle
baseline StO2 is slightly lower in septic shock patients than in
healthy controls; and only the StO2 reperfusion slope and not
the occlusion slope is slower in septic shock than in healthy
controls. In addition, the StO2 reperfusion slope was lower at
day 1 in nonsurvivors than in survivors and predicted out-
come within 28 days. The LD data, although abnormal, did
not correlate well with StO2 parameters. The link between
systemic hemodynamic or metabolic parameters with the
StO2 reperfusion slope suggests an impact on tissue micro-
oxygenation, even if their respective role cannot be precisely
determined.
The development of non-invasive bedside tools to assess
microperfusion alterations has prompted clinicians to look at
the previously recognized and demonstrated microcirculation
impairment occurring in severe sepsis or septic shock
[3,5,37]. Among these tools, some image microvessel flowing
conditions, such as sublingual orthogonal polarisation
spectral (OPS) or sidestream dark field (SDF) [5,38], some
evaluate local tissue perfusion as carbon dioxide tonometry
[39], some measure local tissue microvessel blood flow such
as LD [35] and, finally, some assess tissue micro-oxygenation
by NIRS [24].
NIRS uses the differential absorption properties of oxy-
genated and deoxygenated hemoglobin to evaluate oxygena-
tion of tissues such as skeletal muscle. Near-infrared light
(680 to 800 nm) easily crosses biological tissues, which have
a low absorption power, and is absorbed only by hemoglobin,
myoglobin, and oxidized cytochrome, with the contribution of
the latter two to the light attenuation signal being very small
[30]. NIRS has several advantages since, in addition to being
non-invasive, it is easy to use, does not require expertise to
obtain adequate results, and is a continuous method
providing numbers and continuous trends. NIRS has been
used in different clinical conditions such as severe trauma
[13-17], hemorrhagic shock [40,41], cardiogenic shock or
severe cardiac failure [42] and septic shock [18-22]. The
limitations of NIRS should also be mentioned. Since this
technique does not measure microvessel blood flow or
capillary density, it has a signal ambiguity related to
illumination of venous, capillary and arteriolar vessels. Several
parameters can be obtained from NIRS numerical data, as
demonstrated by De Blasi and colleagues [24]. Among these,
the simplest parameters and the most understandable by the
clinician are the baseline StO2 and the functional regional
circulatory test (VOT) response [24]. The VOT was
developed in septic shock because baseline StO2 did not
clearly differ from controls [14-18], contrary to hemorrhagic
trauma situations [40,41].
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Figure 3
Correlation between central venous oxygen saturation and tissue
hemoglobin oxygen saturation. Correlation between central venous
oxygen saturation (SvO2) and tissue hemoglobin oxygen saturation
(StO2) obtained during the first day of septic shock.The initial studies on sepsis, severe sepsis or septic shock
[14-17] have reported small differences in baseline StO2
compared with healthy controls. We confirm in the present
study such a small, though significant, difference. Since the
StO2 value at the thenar eminence is higher than the central
SvO2 and lower than SpO2, we analyzed the potential
meaning of the gradients between StO2 and these other
oxygen saturations. Gradients did not differ between survivors
and nonsurvivors, but, since their evolution was not studied,
further investigation might be important to evaluate a potential
impact on outcome or severity. We also found no correlation
between SpO2 and StO2 or between StO2 and SvO2.
Whether ScvO2 is an adequate surrogate for SvO2 has been
a matter of continuous debate. We pooled ScvO2 + 5% and
SvO2 values for the analysis. Both parameters are low in early
septic shock and have been shown to be useful to detect and
treat global tissue hypoxia during the resuscitation period.
Although the absolute values of ScvO2 and SvO2 differ,
studies have consistently shown close trends and tracking
between the two in several hemodynamic conditions. The
presence of a low ScvO2 indicates even lower SvO2, the
difference being (on average) approximately 5%. If joining
both sources might have induced a small inaccuracy in the
step-by-step numerical StO2–SvO2 gradient, therefore, this
does not alter the fact that there was no correlation between
them.
Many studies have also reported the time variations of StO2
slopes during the VOT, even when performed with different
protocols – time to reach a low threshold of 40% [15,19] or a
duration of 3 to 5 minutes of occlusion [18,20-22]. The
Critical Care    Vol 13 Suppl 5 Payen et al.
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Figure 4
Correlation between hemodynamic and metabolic parameters and occlusion and reperfusion slopes. (a) Correlation between tissue hemoglobin
oxygen saturation (StO2) occlusion and reperfusion slopes for 98 measurements performed on 43 patients (day 1, 43 measurements; day 2, 34
measurements; day 3, 21 measurements) during the first 3 days of septic shock. (b) Correlation between reperfusion slope and cardiac output
(CO) obtained for 77 measurements, corresponding to 33 patients on day 1, 28 patients on day 2, and 16 patients on day 3. (c) Correlation
between lactate plasma concentration and reperfusion slope (48 measurements), corresponding to 23 patients measured on day 1, 18 patients on
day 2, and seven patients on day 3. (d) Correlation between the reperfusion slope obtained with laser Doppler and the one obtained with StO2
during the simultaneous occlusion tests: 37 measurements were obtained, on 15 patients on day 1, 13 patients on day 2, and nine patients on day
3. TPU, tissue perfusion units.present study confirms the previous results for baseline StO2
and for StO2  occlusion and reperfusion slopes [20-22].
Clearly, the StO2 reperfusion slope appears the most
discriminating parameter for sepsis severity, as previously
mentioned [22]. The reperfusion slope was slower in septic
shock than in severe sepsis and was comparable with the
values we obtained.
In addition, we observed for the first time that the StO2
reperfusion slope within the first 24 hours of septic shock
was different between survivors and nonsurvivors at 28 days
in this homogeneous population. Considering this difference,
we decided to look at the predictive value for outcome of this
parameter alone, in comparison or in combination with the
SOFA score. Using multivariate analysis, we observed a good
predictive value of the StO2 reperfusion slope, although not
superior to the day 1 SOFA score. Unlike the SOFA score,
however, the StO2 reperfusion slope can be obtained several
times a day. Taking into account the number of StO2 values
measured during the reperfusion time (one value every
3 seconds), only five or six values can be obtained. This small
number of values may induce error in the slope calculation,
especially if the tracing is not linear. Consequently, we
decided to apply the linear adjustment model and check the
R2 value. It was only when R2 was >0.90 that we took the
linear slope value. Nonlinear reperfusion tracings were
observed in 20% of the performed VOTs. The recent
development of the incorporated software in the device has
integrated this calculation online.
Although performed on both severe sepsis patients and
septic shock patients, the reported area under the receiver
operating characteristic curve for the StO2 reperfusion slope
outcome predictive value [22] was comparable with the one
we obtained in septic shock patients (0.797 vs. 0.77,
respectively), suggesting a good reproducibility. The calcu-
lated threshold for the reperfusion slope (2.83%/second)
was also very similar to the one previously reported
(2.55%/second) [22], with a sensitivity of 80% and a
specificity of 67%. This area under the curve was also similar
to that obtained with day 1 SOFA values (0.79). Combining
the StO2 reperfusion slope and SOFA score predictive
values showed a significant amelioration of predictive value,
raising the area under the curve to 0.85.
As the most discriminating parameter for outcome and
severity [22], the determinants of the StO2 reperfusion slope
require discussion. The relationship with macrohemo-
dynamics is the first line of investigation. We observed a
significant relation only between cardiac output and the StO2
reperfusion slope, which has never been reported before in
septic shock – such a relation had only been shown in severe
cardiac failure [42]. Although weak (P <0.01), the relation
indicates that systemic flow influences thenar StO2.
Classically in septic shock, adequacy of perfusion for oxygen
demand is assessed by the blood lactate level. In the present
study, the lactate level logically negatively correlated with the
StO2 reperfusion slope, which was slower when lactate levels
were higher. This suggests that NIRS can detect poor tissue
oxygenation or bad vascular reserve that results in lactate
elevation during septic shock. Taking these relationships
(cardiac output and lactate) into account, it is reasonable to
think that poor perfusion at the systemic level influences an
abnormal StO2 reperfusion slope. Separating the
hyperproduction of lactate from a stagnant elevation of
lactate level is not possible due to poor washout.
The second line of determinants may relate to local perfusion,
which may be impaired because of low microvessel blood
flow or the low density of perfused microvessels. In addition,
changes in vascular blood compartmentalization between
venules, capillaries and small arteries may also influence the
StO2 measurement. Despite limitations, initial investigation of
these determinants was made measuring forearm skin blood
flow using LD at baseline and during the same VOT
performed for StO2. In this population of septic shock
patients, the LD baseline and the VOT response were
abnormal in comparison with healthy volunteers. The
abnormal hyperemic response has been attributed to an
abnormal capability of the vessels to dilate after ischemia,
mediated by a deficit in vasodilatating substances such as
prostaglandins or nitric oxide [2,6,9,43]. The nearly significant
(P = 0.08) correlation between LD and the StO2 reperfusion
slopes is important, since the relation between skin LD and
StO2 parameters has not been reported previously. The
slower the StO2 slope, the slower the reperfusion slope of
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Figure 5
Predictive value on outcome. Area under the curve (AUC) for the
multivariate model using each determinant alone or in combination
(solid curve). Se, sensitivity; SOFA, Sequential Organ Failure
Assessment; Sp, specificity.the LD. The combination of a small number of patients and
the differences between skin blood flow and skeletal muscle
flow regulations may explain the weakness of the correlation
[33]. This suggests a potential impact of microvessel blood
flow in the observed abnormal StO2 reperfusion slope.
The observed strong correlation between StO2 occlusion and
reperfusion slopes needs further discussion; that is, the
deeper the occlusion slope, the faster the reperfusion slope.
The explanation for such an observation can only be
speculated on the basis of the previous demonstration of the
determinants of these slopes [15,19-22,24]. The StO2
occlusion slope seems to relate primarily to muscle oxygen
consumption. It was shown that the higher the muscle oxygen
consumption, the faster will be the StO2 decay over time [18-
21,24]. In our septic shock population, the correlation may
depend on the importance of muscle ischemia created by the
VOT. Occurring faster after occlusion, the ischemia will be
longer – which might induce a more pronounced muscle
ischemia, with the release of more vasodilating substances.
This aspect requires further investigation for clarification.
Conclusion
In the present study, the StO2 reperfusion slope is an early
predictive value for outcome in septic shock patients. Its
performance improves when combined with well-known
severity scores. Some relations between macroperfusion and
microperfusion influence the measured StO2 variables. When
StO2 baseline values indicate adequate perfusion, but
microcirculatory dysfunction is suspected, the use of the VOT
seems promising for a functional microperfusion evaluation.
Because of the intricate determinants of microperfusion, a
multimodal assessment to better characterize microperfusion
is needed. Further studies are warranted to validate the NIRS
measurements using a different probe (15 mm) working more
superficially in the thenar eminence than the probe used
initially (25 mm).
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